CS220569B1 - Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same - Google Patents
Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same Download PDFInfo
- Publication number
- CS220569B1 CS220569B1 CS816459A CS645981A CS220569B1 CS 220569 B1 CS220569 B1 CS 220569B1 CS 816459 A CS816459 A CS 816459A CS 645981 A CS645981 A CS 645981A CS 220569 B1 CS220569 B1 CS 220569B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- chloro
- substituted
- formula
- methyl
- general formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- -1 4-chloro-3-sulphamoylbenzoyl halide Chemical class 0.000 claims abstract description 3
- 230000010933 acylation Effects 0.000 claims abstract description 3
- 238000005917 acylation reaction Methods 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 150000002429 hydrazines Chemical class 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims abstract 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- SCYSJFKWFQZRJW-UHFFFAOYSA-N 4-chloro-3-sulfamoylbenzoyl chloride Chemical compound NS(=O)(=O)C1=CC(C(Cl)=O)=CC=C1Cl SCYSJFKWFQZRJW-UHFFFAOYSA-N 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- KAPJGZDRPBUZMF-UHFFFAOYSA-N 5-(anilinocarbamoyl)-2-chlorobenzenesulfonamide Chemical class C1=C(Cl)C(S(=O)(=O)N)=CC(C(=O)NNC=2C=CC=CC=2)=C1 KAPJGZDRPBUZMF-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000012433 hydrogen halide Substances 0.000 claims 1
- 229910000039 hydrogen halide Inorganic materials 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002934 diuretic Substances 0.000 abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 3
- 230000001882 diuretic effect Effects 0.000 abstract description 3
- 230000000894 saliuretic effect Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NQSIARGGPGHMCG-UHFFFAOYSA-N 1-ethyl-1-phenylhydrazine Chemical compound CCN(N)C1=CC=CC=C1 NQSIARGGPGHMCG-UHFFFAOYSA-N 0.000 description 1
- MWOODERJGVWYJE-UHFFFAOYSA-N 1-methyl-1-phenylhydrazine Chemical compound CN(N)C1=CC=CC=C1 MWOODERJGVWYJE-UHFFFAOYSA-N 0.000 description 1
- MOULQPGXSGVJOS-UHFFFAOYSA-N 2-chloro-5-[(N,4-dimethylanilino)carbamoyl]benzenesulfonamide Chemical compound CN(C1=CC=C(C=C1)C)NC(C1=CC(=C(C=C1)Cl)S(N)(=O)=O)=O MOULQPGXSGVJOS-UHFFFAOYSA-N 0.000 description 1
- OKKVBSAIAFLLCS-UHFFFAOYSA-N 2-chloro-5-[(N-phenylanilino)carbamoyl]benzenesulfonamide Chemical compound NS(=O)(=O)C1=C(Cl)C=CC(=C1)C(=O)NN(C1=CC=CC=C1)C1=CC=CC=C1 OKKVBSAIAFLLCS-UHFFFAOYSA-N 0.000 description 1
- XUYCGRVSLQWSNY-UHFFFAOYSA-N 2-chloro-5-[(n-propan-2-ylanilino)carbamoyl]benzenesulfonamide Chemical compound C=1C=CC=CC=1N(C(C)C)NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 XUYCGRVSLQWSNY-UHFFFAOYSA-N 0.000 description 1
- OYNAHVKIPRBYNQ-UHFFFAOYSA-N 2-chloro-5-[[N-(2-hydroxyethyl)anilino]carbamoyl]benzenesulfonamide Chemical compound OCCN(C1=CC=CC=C1)NC(C1=CC(=C(C=C1)Cl)S(N)(=O)=O)=O OYNAHVKIPRBYNQ-UHFFFAOYSA-N 0.000 description 1
- LBXHRAWDUMTPSE-AOOOYVTPSA-N 4-chloro-N-[(2S,6R)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide Chemical compound C[C@H]1CCC[C@@H](C)N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 LBXHRAWDUMTPSE-AOOOYVTPSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- VPGRYOFKCNULNK-ACXQXYJUSA-N Deoxycorticosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 VPGRYOFKCNULNK-ACXQXYJUSA-N 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960004070 clopamide Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
- 229960004569 indapamide Drugs 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QWNNFYQUBPILCG-UHFFFAOYSA-N metipamide Chemical compound C=1C=CC=CC=1N(C)NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 QWNNFYQUBPILCG-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C301/00—Esters of sulfurous acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS816459A CS220569B1 (en) | 1981-09-01 | 1981-09-01 | Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same |
| FR828212899A FR2512018B1 (fr) | 1981-09-01 | 1982-07-23 | N-anilino-4-chloro-3-sulfamoylbenzamides substituees et procede pour leur fabrication |
| GB08221558A GB2104891B (en) | 1981-09-01 | 1982-07-26 | N-aniline-4-chloro-3-sulphamoyl benzamides |
| DE19823229453 DE3229453A1 (de) | 1981-09-01 | 1982-08-06 | Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide, ihre herstellung und pharmazeutische mittel |
| CA000410121A CA1187899A (en) | 1981-09-01 | 1982-08-25 | Substituted n-aniline-4-chloro-3-sulphamoyl benzamides |
| CH5145/82A CH649989A5 (de) | 1981-09-01 | 1982-08-30 | Substituierte n-anilino-4-chlor-3-sulfamoylbenzamide. |
| JP57150823A JPS5859961A (ja) | 1981-09-01 | 1982-09-01 | 置換ｎ−アニリン−４−クロロ−３−スルフアモイルベンズアミド |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS816459A CS220569B1 (en) | 1981-09-01 | 1981-09-01 | Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS220569B1 true CS220569B1 (en) | 1983-04-29 |
Family
ID=5411672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS816459A CS220569B1 (en) | 1981-09-01 | 1981-09-01 | Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5859961A (enrdf_load_stackoverflow) |
| CA (1) | CA1187899A (enrdf_load_stackoverflow) |
| CH (1) | CH649989A5 (enrdf_load_stackoverflow) |
| CS (1) | CS220569B1 (enrdf_load_stackoverflow) |
| DE (1) | DE3229453A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2512018B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2104891B (enrdf_load_stackoverflow) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3088873A (en) * | 1960-02-16 | 1963-05-07 | British Drug Houses Ltd | 4-chloro-3-sulphamyl benzoic acid and salts |
| US3043874A (en) * | 1960-05-09 | 1962-07-10 | Parke Davis & Co | 4-halo-3-sulfamoylbenzoic acid derivatives and methods for producing same |
| DE1181712B (de) * | 1960-06-15 | 1964-11-19 | Ndoz A G S | Verfahren zur Herstellung von 3-Sulfamyl-4-halogen-benzoylhydrazinen |
| GB1406882A (en) * | 1972-04-28 | 1975-09-17 | Leo Pharm Prod Ltd | Benzoic acid derivatives and benzisptjoaup'e 1.1 dopxode derovatoves |
| US4258059A (en) * | 1978-12-15 | 1981-03-24 | Usv Pharmaceutical Corporation | Amino-benzamides |
-
1981
- 1981-09-01 CS CS816459A patent/CS220569B1/cs unknown
-
1982
- 1982-07-23 FR FR828212899A patent/FR2512018B1/fr not_active Expired
- 1982-07-26 GB GB08221558A patent/GB2104891B/en not_active Expired
- 1982-08-06 DE DE19823229453 patent/DE3229453A1/de active Granted
- 1982-08-25 CA CA000410121A patent/CA1187899A/en not_active Expired
- 1982-08-30 CH CH5145/82A patent/CH649989A5/de not_active IP Right Cessation
- 1982-09-01 JP JP57150823A patent/JPS5859961A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3229453C2 (enrdf_load_stackoverflow) | 1988-07-28 |
| GB2104891B (en) | 1985-05-01 |
| FR2512018A1 (fr) | 1983-03-04 |
| DE3229453A1 (de) | 1983-03-10 |
| JPS5859961A (ja) | 1983-04-09 |
| CH649989A5 (de) | 1985-06-28 |
| FR2512018B1 (fr) | 1985-07-26 |
| CA1187899A (en) | 1985-05-28 |
| GB2104891A (en) | 1983-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2655692B2 (ja) | スルホンアミドチエニルカルボン酸化合物 | |
| EP0373998B1 (fr) | Ethers d'oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| FR2530626A1 (fr) | Composes de carbostyryle | |
| CA1212380A (fr) | Procede de preparation de nouveaux derives de thieno (2,3-b) pyrrole | |
| CA1203531A (en) | 1-substituted n-(8 alfa-ergolinyl)-n',n' diethyl- ureas and processes for producing thereof | |
| JPS6121235B2 (enrdf_load_stackoverflow) | ||
| CA2451979A1 (en) | Novel modifications of the trometamol salt of r-thioctic acid and method for producing the same | |
| CS220569B1 (en) | Substituted n-aniline-4-chloro-3-sulphamoylbenzamides and method of preparing same | |
| PT87162B (pt) | Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos | |
| FI57586C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbart 1-(2-(beta-naftyloxi)-etyl)-3-metyl-pyrazolon-(5) | |
| US4424361A (en) | Process for preparing polycyclic triazoles used to inhibit allergic responses | |
| RU2069212C1 (ru) | Производные имидазола | |
| SU880251A3 (ru) | Способ получени производных тиохромана или их солей | |
| EP0275762B1 (fr) | Dérivés de l'indole carboxamide ainsi que leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments de ces dérivés et compositions les renfermant | |
| US4355166A (en) | Quinuclidinic ester and derivatives of phenoxycarboxylic acids | |
| EP0018732B1 (en) | An alpha-methyl-4(2'-thienyl-carbonyl)phenyl acetic acid derivative, process for its preparation and its pharmaceutical use | |
| US4879404A (en) | Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same | |
| EP0076600A1 (en) | Anthranilic acid esters | |
| FI81782C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-styrensulfonyl-2-oxo-5-hydroxi-pyrrolidinderivat. | |
| US4613695A (en) | N-nitroso compounds and compositions containing such compounds | |
| KR840001613B1 (ko) | 퀴놀론 화합물의 제조방법 | |
| JPS5810387B2 (ja) | ４，５，６，７テトラヒドロイミダゾ〔４，５−ｃ〕ピリジン誘導体及びその製法 | |
| FR2511677A1 (fr) | Procede de preparation d'esters des acides alcoxyvincaminiques et alcoxyapovincaminiques | |
| US4900841A (en) | 1-[4-[(methyl-sulfonyl)amino]benzoyl]aziridine | |
| HU196771B (en) | Process for production of intermediers of derivatives of oxo-oxazolidinil-benzol having antibacterial effect |